CN101721550A - Medicine used after fracture taxis - Google Patents

Medicine used after fracture taxis Download PDF

Info

Publication number
CN101721550A
CN101721550A CN200810194996A CN200810194996A CN101721550A CN 101721550 A CN101721550 A CN 101721550A CN 200810194996 A CN200810194996 A CN 200810194996A CN 200810194996 A CN200810194996 A CN 200810194996A CN 101721550 A CN101721550 A CN 101721550A
Authority
CN
China
Prior art keywords
fracture
taxis
medicine
raw materials
medicine used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810194996A
Other languages
Chinese (zh)
Inventor
徐瑞兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810194996A priority Critical patent/CN101721550A/en
Publication of CN101721550A publication Critical patent/CN101721550A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine used after fracture taxis, which is prepared by taking ground beetle, mastic, myrrh, astragalus root, the fruit of Chinese wolfberry and cassia twig as raw materials. The invention has good use effect and definite curative effect and can diminish inflammation and alleviate pain/promote healing.

Description

The medicine of used after fracture taxis
Technical field:
The present invention relates to a kind of medicine of used after fracture taxis.
Background technology:
The medicine of existing used after fracture taxis generally adopts Western medicine etc., and to part patient unsatisfactory curative effect, what have has certain side reaction.
Summary of the invention:
The object of the present invention is to provide the medicine of the good used after fracture taxis of a kind of therapeutic effect.
Technical solution of the present invention is:
A kind of medicine of used after fracture taxis is characterized in that: made by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 20～30%
Olibanum 15～25%
Myrrha 5～15%
The Radix Astragali 10～25%
Fructus Lycii 10～25%
Ramulus Cinnamomi 10～25%.
The medicine of described used after fracture taxis, make by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 25%
Olibanum 20%
Myrrha 5%
The Radix Astragali 20%
Fructus Lycii 10%
Ramulus Cinnamomi 20%.
Result of use of the present invention is good, determined curative effect, but antiinflammatory, pain relieving/promotion healing.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
A kind of medicine of used after fracture taxis, make by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 25%
Olibanum 20%
Myrrha 5%
The Radix Astragali 20%
Fructus Lycii 10%
Ramulus Cinnamomi 20%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.
Embodiment 2:
A kind of medicine of used after fracture taxis is characterized in that: made by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 20%
Olibanum 25%
Myrrha 10%
The Radix Astragali 15%
Fructus Lycii 15%
Ramulus Cinnamomi 15%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.

Claims (2)

1. the medicine of a used after fracture taxis is characterized in that: made by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 20～30%
Olibanum 15～25%
Myrrha 5～15%
The Radix Astragali 10～25%
Fructus Lycii 10～25%
Ramulus Cinnamomi 10～25%.
2. the medicine of used after fracture taxis according to claim 1 is characterized in that: made by following raw materials by weight percent:
Eupolyphaga Seu Steleophaga 25%
Olibanum 20%
Myrrha 5%
The Radix Astragali 20%
Fructus Lycii 10%
Ramulus Cinnamomi 20%.
CN200810194996A 2008-10-27 2008-10-27 Medicine used after fracture taxis Pending CN101721550A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810194996A CN101721550A (en) 2008-10-27 2008-10-27 Medicine used after fracture taxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810194996A CN101721550A (en) 2008-10-27 2008-10-27 Medicine used after fracture taxis

Publications (1)

Publication Number Publication Date
CN101721550A true CN101721550A (en) 2010-06-09

Family

ID=42443500

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810194996A Pending CN101721550A (en) 2008-10-27 2008-10-27 Medicine used after fracture taxis

Country Status (1)

Country Link
CN (1) CN101721550A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103638116A (en) * 2013-12-18 2014-03-19 青岛市市立医院 Auxiliary natural compound traditional Chinese medicine for osteosynthesis
CN105381083A (en) * 2015-12-09 2016-03-09 长顺县文会虫草种植有限公司 Thrombolytic cordyceps sinensis healthcare wine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103638116A (en) * 2013-12-18 2014-03-19 青岛市市立医院 Auxiliary natural compound traditional Chinese medicine for osteosynthesis
CN105381083A (en) * 2015-12-09 2016-03-09 长顺县文会虫草种植有限公司 Thrombolytic cordyceps sinensis healthcare wine

Similar Documents

Publication Publication Date Title
CN101721616A (en) Medicine for stopping bleeding
CN101721550A (en) Medicine used after fracture taxis
CN101843861B (en) Chinese medicinal composition for treating tonsillitis
CN103169855A (en) Drug composition for treating chronic heart failure
CN103536774A (en) Electuary for treating thirst
CN103566215B (en) Musk bone-strengthening paste
CN102552511B (en) Medicament for treating diarrhea
CN101773617A (en) Drug for treatment of asthmatic bronchitis
CN104666449A (en) Health medicine for nasal cavity
CN103656129A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN102743707A (en) Pill for treating acute lumbar sprain
CN102423434A (en) Medicament for treating eczema
CN100540043C (en) A kind of treatment hypertension drug
CN101721541A (en) Medicine for treating erysipelas
CN104706992A (en) Lung astringing and cough relieving traditional Chinese medicine composition
CN101773587A (en) Drug for treatment of bronchitis
CN101721473A (en) Medicine for preventing asthma
CN101181409A (en) Chinese medicinal composition for treating female menoxenia
CN104666573A (en) Traditional Chinese medicine for treating chilblain
CN103751469A (en) Composition for treating qi and blood stasis type systemic scleroderma
CN101181367A (en) Chinese medicine for curing menorrhalgia
CN101181454A (en) Chinese medicine composition for curing women's redundant menses
CN101766798A (en) Medicament for treating chronic superficial gastritis
CN101628072A (en) Chinese herbal medicament for treating cancer
CN1879820A (en) Chinese herbal medicine for treating schizophrenia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100609